Form 4: RxSight CFO Shelley Thunen Executes Stock Option and Sells Shares

Shelley Thunen, CFO of RxSight, exercised stock options and sold shares of the company's common stock on October 1, 2024, according to a Form 4 filing with the SEC.

Summary

• On October 1, 2024, Shelley Thunen, the CFO of RxSight, Inc., exercised a stock option to acquire 15,000 shares of common stock at a price of $16 per share.
• Following the exercise, Thunen sold a total of 15,000 shares in multiple transactions at weighted average prices ranging from $47.9566 to $49.45.
• These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 14, 2023.
• After these transactions, Thunen directly owns 30,443 shares of RxSight common stock and holds options for 83,367 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports routine stock transactions by a company executive under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's performance and future prospects. Rule 10b5-1 plans are frequently used to allow insiders to sell shares without being accused of trading on non-public information.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the impact is likely minimal given the relatively small number of shares involved.

Key Dates